A structured recommendation workflow at a community pharmacy was associated with more multivaccine patients than routine practice.
Feature|Articles|August 17, 2026
Competing Vaccine Schedules Leave Pharmacists Navigating Confusion
Author(s)Ashley Gallagher, MA
A year of ACIP turnover, schedule changes, and lawsuits has fractured US vaccine guidance—and tied pharmacists' scope and billing to a moving target.
Advertisement
Advertisement
For more than 60 years, the Advisory Committee on Immunization Practice (ACIP), a committee of scientific and health experts, has driven federal vaccine recommendations later adopted by the CDC.¹ Since United States Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr was sworn in on February 13, 2025, that process has been upended through committee turnover, unilateral recommendation changes, ongoing litigation, and, most recently, competing vaccine schedules from federal agencies and nonfederal medical societies alike.
Related to this article
Researchers compared vaccine coadministration with single-dose, sequential vaccination for the RSVPreF3 OA vaccine formulation in adults.
Availability will vary by state, and a pharmacy professor says cost barriers can keep families from getting vaccinated.
Darren Mensch, PharmD, BCPS, BCACP, provides evidence-based nuance regarding the emergence of mRNA vaccine technology and health care’s understanding of it.
Pharmacist pain clinics typically focus on comprehensive medication management involving the entire patient scenario.
A case shows a suspected recurrence of pneumococcal disease that ended with removal of one cochlear implant and replacement of the other.
Detailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity.
In celebration of the organization’s recent convention, NCPA released its annual digest report for members, providing a detailed overview of independent community pharmacy.
Advertisement
Advertisement